| ²é¿´: 349 | »Ø¸´: 2 | |||
С²Ý_ÏÊ»¨Ð³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÇóÖúһƪÎÄÕ£ºCharacterization of human ovarian carcinoma-associated antigens ÒÑÓÐ1È˲ÎÓë
|
| Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity |
» ²ÂÄãϲ»¶
ÄϾ©ÏþׯѧԺÂÌÉ«ÄÜÔ´²ÄÁÏÍŶÓÕÐÉú
ÒѾÓÐ0È˻ظ´
±±·½¹¤Òµ´óѧ´¢Äܼ¼Êõ-02µç»¯Ñ§´¢ÄÜÓëÇâÄÜ·½ÏòÕÐÊÕ2026¼¶¶þ´Îµ÷¼ÁѧÉú
ÒѾÓÐ0È˻ظ´
ÎÞ»ú»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ219È˻ظ´
ÇóÖúWO3.cifÎļþ ¶ÔÓ¦PDF¿¨Æ¬ 43-1035£¬µ¥Ð±¾§Ïµ , P21/n ¡£
ÒѾÓÐ2È˻ظ´
Ï¡ÍÁ·¢¹â·ÖÎö£üºË¿Ç½á¹¹£üÊÙÃüÄâºÏ
ÒѾÓÐ8È˻ظ´
Ï¡ÍÁ·¢¹â·ÖÎö£üºË¿Ç½á¹¹£üÊÙÃüÄâºÏ
ÒѾÓÐ10È˻ظ´
Ï¡ÍÁ·¢¹â·ÖÎö£üºË¿Ç½á¹¹£üÊÙÃüÄâºÏ
ÒѾÓÐ6È˻ظ´
Ï¡ÍÁ·¢¹â·ÖÎö£üºË¿Ç½á¹¹£üÊÙÃüÄâºÏ
ÒѾÓÐ0È˻ظ´
Ï¡ÍÁ·¢¹â·ÖÎö£üºË¿Ç½á¹¹£üÊÙÃüÄâºÏ
ÒѾÓÐ0È˻ظ´
26 ½ìÇൺ´óѧ·ÄÖ¯»¯Ñ§ÓëȾÕû¹¤³Ì˶ʿ£¨ÒºÌåÄÉÃ×·ÖɢȾÁÏ·½Ïò£©ÇóÉ격½¨Òé
ÒѾÓÐ3È˻ظ´
26 ½ìÇൺ´óѧ·ÄÖ¯»¯Ñ§ÓëȾÕû¹¤³Ì£¨ÒºÌåÄÉÃ×·ÖɢȾÁÏ£©ÇóÕãÀí¹¤·ÄÖ¯ / ²ÄÁϲ©µ¼Ãû¶î
ÒѾÓÐ0È˻ظ´
huaiji
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 11943.6
- ºì»¨: 5
- Ìû×Ó: 884
- ÔÚÏß: 292.1Сʱ
- ³æºÅ: 1540206
- ×¢²á: 2011-12-16
- ÐÔ±ð: GG
- רҵ: ÀíÂۺͼÆË㻯ѧ

2Â¥2014-04-02 07:52:51
huaiji
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 11943.6
- ºì»¨: 5
- Ìû×Ó: 884
- ÔÚÏß: 292.1Сʱ
- ³æºÅ: 1540206
- ×¢²á: 2011-12-16
- ÐÔ±ð: GG
- רҵ: ÀíÂۺͼÆË㻯ѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
| ÎÄÏ×Òѵõ½£¬Çë²éÊÕ£¡ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : CHARACTERIZATIONOFHUMANOVARIANCARCINOMA-ASSOC.pdf
2014-04-02 20:59:21, 1018.68 K

3Â¥2014-04-02 20:59:31













»Ø¸´´ËÂ¥
20